# FDA Inspection 1269430 - Biohaven Pharmaceuticals. Inc. - April 24, 2025

Source: https://www.keypedia.com/records/fda_inspections/biohaven-pharmaceuticals-inc/0feddefd-4fa4-4e3a-bc32-50d721f8390e
Source feed: FDA_Inspections

> FDA Inspection 1269430 for Biohaven Pharmaceuticals. Inc. on April 24, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269430
- Company Name: Biohaven Pharmaceuticals. Inc.
- Inspection Date: 2025-04-24
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1269430 - 2025-04-24](https://www.keypedia.com/records/fda_inspections/biohaven-pharmaceuticals-inc/c42c85cf-1bf3-4858-9681-b420e194f3e2)
- [FDA Inspection 1180548 - 2022-09-09](https://www.keypedia.com/records/fda_inspections/biohaven-pharmaceuticals-inc/8f05470f-2cde-4530-839d-7ae7eb4dc410)
- [FDA Inspection 1112681 - 2019-11-07](https://www.keypedia.com/records/fda_inspections/biohaven-pharmaceuticals-inc/30490e85-97bd-4b92-82e9-4fa96eea48d7)

Company: https://www.keypedia.com/companies/biohaven-pharmaceuticals-inc/cad96470-9095-49f8-9bed-2444d3d26a63

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c